Inventor · disambiguated record
William Vainchenker
Also filed as: VAINCHENKER WILLIAM
14 granted patents·4 pending applications·74 citations·filing 1994–2021
91Inventor score
Files withROUSSY INST GUSTAVE6VAINCHENKER WILLIAM3INST NAT SANTE RECH MED2VIGUIE FRANCK2AMINE ABINA1
Top patents by PatentIndex Score
18 records- 0188US7781199B2Identification of a JAK2 mutation involved in Vaquez PolyglobuliaVAINCHENKER WILLIAM·Filed 2005·Granted Aug 24, 2010·11 cites·16 claims
- 0287US8637235B2Identification of a JAK2 mutation in polycythemia veraVAINCHENKER WILLIAM·Filed 2008·Granted Jan 28, 2014·10 cites·3 claims
- 0384US8852931B2Identification of a JAK2 mutation involved in vaquez polyglobuliaAssistance Publique—Hopitaux de Paris·Filed 2013·Granted Oct 7, 2014·9 cites·11 claims
- 0484US7429456B2Identification of a JAK2 mutation in Polycythemia VeraIPSOGEN·Filed 2007·Granted Sep 30, 2008·12 cites·7 claims
- 0578US9389233B2TET2 as a diagnostic and pronostic marker in hematopoietic neoplasmsVIGUIE FRANCK·Filed 2009·Granted Jul 12, 2016·3 cites·10 claims
- 0678US2022042016A1Identification of a JAK2 Mutation in Polycythemia VeraROUSSY INST GUSTAVE·Filed 2021·Application pending·0 cites
- 0775US10662482B2TET2 as a diagnostic and prognostic marker in hematopoietic neoplasmsINST NAT SANTE RECH MED·Filed 2016·Granted May 26, 2020·1 cites·13 claims
- 0873US11162100B2Identification of a JAK2 mutation in polycythemia veraROUSSY INST GUSTAVE·Filed 2020·Granted Nov 2, 2021·0 cites·8 claims
- 0972US6464998B1Composition for the in vivo production of therapeutic productsAVENTIS PHARMA SA·Filed 1994·Granted Oct 15, 2002·28 cites·25 claims
- 1070US10563200B2Identification of a JAK2 mutation in Polycythemia VeraROUSSY INST GUSTAVE·Filed 2019·Granted Feb 18, 2020·0 cites·3 claims
- 1167US11203788B2TET2 as a diagnostic and pronostic marker in hematopoietic neoplasmsINST NAT SANTE RECH MED·Filed 2020·Granted Dec 21, 2021·0 cites·3 claims
- 1262US10364430B2Identification of a JAK2 mutation in polycythemia veraROUSSY INST GUSTAVE·Filed 2014·Granted Jul 30, 2019·0 cites·3 claims
- 1358US8466338B2Identification of a JAK2 mutation involved in vaquez polyglobuliaVAINCHENKER WILLIAM·Filed 2011·Granted Jun 18, 2013·0 cites·2 claims
- 1447US2015232932A1Ankrd26 as a marker for diagnosis of thrombocytopeniasROUSSY INST GUSTAVE·Filed 2013·Application pending·0 cites
- 1547US2010120663A1Method for inducing thrombopoiesisAMINE ABINA·Filed 2008·Application pending·0 cites
- 1643US9297046B2TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasmsVIGUIE FRANCK·Filed 2012·Granted Mar 29, 2016·0 cites·7 claims
- 1742US2013344494A1Myh10 as a new marker of pathologies resulting from runx1 inactivationBLUTEAU DOMINIQUE·Filed 2012·Application pending·0 cites
- 1841US11732303B2Prognostic marker for myeloproliferative neoplasmsROUSSY INST GUSTAVE·Filed 2016·Granted Aug 22, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when William Vainchenker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →